Google
 
Web cbwinfo.com
Home News History General Links Bookstore
Biological Gateway Chemical Gateway Radiological Gateway

Venezuelan Equine Encephalitis:
essential data

Viral weapon acting on
humans and livestock

Synopsis, Diagnosis, Symptoms,
Countermeasures, Properties and Uses, Terrorist Interest, IDC Codes

 

Safety Precautions for Venezualan Equine Encephalitis Casualties

Standard Precautions defined by the 1996 CDC guidelines should be adopted for handling patients.

 Droplet precautions may also be necessary.

 Mosquito control should be practiced.

Biosafety level 3 practices should be adopted for handling of samples.

Return to Top

Synopsis of Agent Properties

Causative organism: 
(Systematic name in 1997)
Venezuelan equine encephalitis virus
ICTV Acronym VEEV
Alternative disease names: none 
Properties: A positive-sense, single-stranded RNA virus.
Click here for a detailed description of Alphaviruses
Vector involvement: The disease is carried by culicine mosquitoes, especially Culex tarsalis.

 

Return to Top

 

Key Diagnostic Tests.

Sudden severe headache, chills, fever, muscle pain are the commonest symptoms.
Return to Top
Symptoms and effects.

After an incubation of 2-6 days (as little as one day has been seen), there is a sudden onset of flu-like symptoms including a severe headache, chills, fever, retro-orbital pain (pain behind the eyes), congestion, nausea and vomiting. Lymphadenopathy is seen in about a third of cases. Most cases are mild and symptoms last 3-5 days. The disease can be biphasic with a return of more severe symptoms at 6-9 days after onset.

In severe cases the virus invades the central nervous system leading to encephalitis disorientation, convulsions, paralysis and coma.   Adults are relatively resistant to the disease with <10% dying, but 20-30% of children affected may die.

Return to Top

Medical and Physical Countermeasures.

Vaccination (Immunoprophylaxis)

Vaccines with providing limited protection are available to investigators in the United States. Approximately 20% of people do not respond to the DOD TC-83 vaccine that has IND (investigative new drug) status and about 20% require 1-2 days rest after vaccination. It is not effective against all serotypes of the virus. A formalin-inactivated form of TC-63 (C-84) can be use for those who do not respond to TC-83.

A vaccine may be available from the former Soviet Union.

 Specific Therapy

 No specific therapies are available.

Supportive care

 Symptoms are treated, e.g. with analgesics and anticonvulsants.

Decontamination

The virus is killed by common disinfectants, moist heat and drying. It can survive in dried blood and other secretions so care must be taken to decontaminate surfaces.

Return to Top

Agent Properties and Potential Uses

The virus is highly infective and a single particle may be enough to bring about disease. It is stable in aerosols and in body fluids. It is transmitted by many species of mosquitoes and this may give rise to the development of reservoirs of the virus in rodents and horses.

 The virus is also relatively easy to grow in cell culture and is robust enough to withstand storage and weaponization.

There are 11 subtypes of VEEV, of which three (IA, IB, and IC) can cause epidemics in man. The remainder survive without causing significant disease to their natural host: horses and their relatives.

Return to Top

Terrorist Acquisition and Attempted Use.

Return to Top
International Classification of Disease Codes for Venezuelan Equine Encephalitis
Disease ICD-9-CM ICD-10
Venezuelan equine fever 066.2 A92.2
  Copyright© 1999 CBWInfo.com
Home Copyright Disclaimer
Privacy
Feedback Sponsorship